Concise Reviews: Stem Cells and Kidney Regeneration: An Update
Abstract Significant progress has been made to advance stem cell products as potential therapies for kidney diseases: various kinds of stem cells can restore renal function in preclinical models of acute and chronic kidney injury. Nonetheless this literature contains contradictory results, and for t...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Stem Cells Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/sctm.18-0115 |
id |
doaj-dd3d4e2d938c45bead2127a84abdffec |
---|---|
record_format |
Article |
spelling |
doaj-dd3d4e2d938c45bead2127a84abdffec2020-11-24T21:40:46ZengWileyStem Cells Translational Medicine2157-65642157-65802019-01-0181829210.1002/sctm.18-0115Concise Reviews: Stem Cells and Kidney Regeneration: An UpdateJulia Marcheque0Benedetta Bussolati1Marie Csete2Laura Perin3GOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics, Children's Hospital Los Angeles, Division of Urology Saban Research Institute, University of Southern California Los Angeles CaliforniaDepartment of Molecular Biotechnology and Health Sciences University of Torino ItalyMedical Engineering California Institute of Technology Los Angeles CaliforniaGOFARR Laboratory for Organ Regenerative Research and Cell Therapeutics, Children's Hospital Los Angeles, Division of Urology Saban Research Institute, University of Southern California Los Angeles CaliforniaAbstract Significant progress has been made to advance stem cell products as potential therapies for kidney diseases: various kinds of stem cells can restore renal function in preclinical models of acute and chronic kidney injury. Nonetheless this literature contains contradictory results, and for this reason, we focus this review on reasons for apparent discrepancies in the literature, because they contribute to difficulty in translating renal regenerative therapies. Differences in methodologies used to derive and culture stem cells, even those from the same source, in addition to the lack of standardized renal disease animal models (both acute and chronic), are important considerations underlying contradictory results in the literature. We propose that harmonized rigorous protocols for characterization, handling, and delivery of stem cells in vivo could significantly advance the field, and present details of some suggested approaches to foster translation in the field of renal regeneration. Our goal is to encourage coordination of methodologies (standardization) and long‐lasting collaborations to improve protocols and models to lead to reproducible, interpretable, high‐quality preclinical data. This approach will certainly increase our chance to 1 day offer stem cell therapeutic options for patients with all‐too‐common renal diseases. Stem Cells Translational Medicine 2019;8:82–92https://doi.org/10.1002/sctm.18-0115Adult stem cellsKidneyMesenchymal stem cellsRenal |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Julia Marcheque Benedetta Bussolati Marie Csete Laura Perin |
spellingShingle |
Julia Marcheque Benedetta Bussolati Marie Csete Laura Perin Concise Reviews: Stem Cells and Kidney Regeneration: An Update Stem Cells Translational Medicine Adult stem cells Kidney Mesenchymal stem cells Renal |
author_facet |
Julia Marcheque Benedetta Bussolati Marie Csete Laura Perin |
author_sort |
Julia Marcheque |
title |
Concise Reviews: Stem Cells and Kidney Regeneration: An Update |
title_short |
Concise Reviews: Stem Cells and Kidney Regeneration: An Update |
title_full |
Concise Reviews: Stem Cells and Kidney Regeneration: An Update |
title_fullStr |
Concise Reviews: Stem Cells and Kidney Regeneration: An Update |
title_full_unstemmed |
Concise Reviews: Stem Cells and Kidney Regeneration: An Update |
title_sort |
concise reviews: stem cells and kidney regeneration: an update |
publisher |
Wiley |
series |
Stem Cells Translational Medicine |
issn |
2157-6564 2157-6580 |
publishDate |
2019-01-01 |
description |
Abstract Significant progress has been made to advance stem cell products as potential therapies for kidney diseases: various kinds of stem cells can restore renal function in preclinical models of acute and chronic kidney injury. Nonetheless this literature contains contradictory results, and for this reason, we focus this review on reasons for apparent discrepancies in the literature, because they contribute to difficulty in translating renal regenerative therapies. Differences in methodologies used to derive and culture stem cells, even those from the same source, in addition to the lack of standardized renal disease animal models (both acute and chronic), are important considerations underlying contradictory results in the literature. We propose that harmonized rigorous protocols for characterization, handling, and delivery of stem cells in vivo could significantly advance the field, and present details of some suggested approaches to foster translation in the field of renal regeneration. Our goal is to encourage coordination of methodologies (standardization) and long‐lasting collaborations to improve protocols and models to lead to reproducible, interpretable, high‐quality preclinical data. This approach will certainly increase our chance to 1 day offer stem cell therapeutic options for patients with all‐too‐common renal diseases. Stem Cells Translational Medicine 2019;8:82–92 |
topic |
Adult stem cells Kidney Mesenchymal stem cells Renal |
url |
https://doi.org/10.1002/sctm.18-0115 |
work_keys_str_mv |
AT juliamarcheque concisereviewsstemcellsandkidneyregenerationanupdate AT benedettabussolati concisereviewsstemcellsandkidneyregenerationanupdate AT mariecsete concisereviewsstemcellsandkidneyregenerationanupdate AT lauraperin concisereviewsstemcellsandkidneyregenerationanupdate |
_version_ |
1725924620784107520 |